Modern Ayurveda Brand Kapiva secures over USD 60 Million funding, including USD 28 Million in Primary Capital to Accelerate Innovation

Bengaluru, September 29, 2025: Kapiva, a pioneer in modern Ayurvedic healthcare, today announced that it has raised over USD 60 Million (INR 510 Crores) including USD 28 million (INR 240 crore) of primary in its Series D funding round. The balance was used to give an exit to early investors. The round was led by 360 ONE Asset and Vertex Growth, with participation from existing investors Vertex Ventures Southeast Asia and India, as well as 3one4 Capital.

The fresh capital will be deployed to strengthen Kapiva’s research & development, manufacturing capabilities, invest in brand building at scale, and build a strong health-tech ecosystem.

Over the past three years, Kapiva has delivered over 80% year-on-year growth and achieved an annual revenue run rate (ARR) of over INR 550 Crores, reflecting strong consumer adoption across health and wellness categories. Today, Kapiva employs over 500 people and operates across a robust distribution network spanning general trade, modern trade, pharmacy, digital commerce platforms, and its own website.

"We set out to build consumer trust with evidence, and not just claims," said Ameve Sharma, Founder of Kapiva. "This funding represents confidence in our vision to make Ayurveda the preferred choice for holistic wellness. Our strong results from clinical trials on our Blood Sugar supplement Dia Free Juice and our Sports Nutrition supplement Shilajit Gold, reflects our commitment to products that are both accessible and proven. We are making our products accessible to consumers across channels from our own website to ecommerce and now a fast growing offline channel with a reach of about 40,000 stores."

“Kapiva’s commitment to Scientific Ayurveda—integrating modern science with traditional formulations—has enabled them to create a differentiated product portfolio with strong consumer trust. The wellness industry is experiencing a fundamental shift toward preventive healthcare, and Kapiva’s evidence-based approach focusing on diabetes, hypertension, energy, liver function and other chronic use cases, sets them apart. With a robust R&D engine, proven omnichannel distribution across digital and offline, and an experienced team led by Ameve Sharma, Kapiva is well-positioned to capture the large and growing natural wellness opportunity.” said Chetan Naik, Senior Fund Manager and Strategy Head - Technology, 360 ONE Asset

“India's wellness heritage has global appeal.  Kapiva modernises Ayurveda by taking a scientifically-driven and research-based approach to product development and formulations. We are excited to support Kapiva team’s vision of making clinically validated Ayurvedic products, already leading in categories like diabetes care and fitness, accessible to consumers worldwide.” said James Lee, General Partner, Vertex Growth Fund.

Kapiva has some of the leading products across sports nutrition, daily energy, Diabetes, Blood pressure, Cholesterol, Liver care, Hormonal Balance and daily wellness.

Kapiva has established a robust omnichannel model, with growing traction across general trade, modern trade, and pharmacy channels, supported by digital discovery and repeat usage. It is distributed in about 40,000 stores across India.

Building on this reach, Kapiva’s health tech investment aims to make Ayurveda driven healthcare more accessible and personalized, empowering consumers to better manage chronic conditions and improve long-term wellness through technology-driven solutions.

Avendus Capital acted as the exclusive financial advisor to Kapiva and its shareholders for the transaction.

About Kapiva

Kapiva is a modern Ayurvedic brand that has successfully integrated Ayurveda into the daily lives of consumers by offering simple, accessible, and effective wellness solutions. It offers authentic products using research, science-backed Ayurveda, and the finest ingredients. Kapiva has been a disruptor in the Ayurvedic industry by introducing innovation in product formats that can be easily integrated into people's daily routines. The brand recently expanded globally including the Middle East, Europe and North America with a wholly-owned US subsidiary, Kapiva Inc., and is present across 40,000 stores in India. Its key investors include Orbimed, 360 ONE asset, 3One4 capital, Vertex Ventures SEA and India and Vertex growth.

About 360 ONE Asset

360 ONE Asset is one of India's largest alternative asset managers with AUM of $6 billion as of June 30, 2025. 360 ONE Asset's premier venture capital and private equity platform has an AUM of $3.6 billion, 85 portfolio companies and a seasoned investment team in Mumbai and Bangalore. The platform spans the entire company life cycle, from Idea to IPO, offering investment solutions across Venture Capital, Growth Equity, Late-Stage PE and pre-IPO, Secondaries and Fund-of-Funds. The platform also has deep domain expertise in technology, consumer, healthcare, financial services and industrials/manufacturing coupled with a deep understanding of Indian capital markets. It has a 10-year track record of successfully partnering with founders and of innovation, consistently bringing new offerings to the Indian market. 360 ONE Asset was recently awarded ‘Best Private Equity House’ at the Global Private Banking Innovation Awards 2025.  It also won ‘Best Private Equity House’ at the Finance Asia Achievement Awards in 2023 (Winner) and 2024 (Highly Commended). More information is available at: https://www.360.one/asset

About Vertex Growth

Vertex Growth is dedicated to partnering with exceptional entrepreneurs and promising companies on the cusp of growth. The firm provides expansion capital to realise the companies’ vision of creating a category champion that is enduring and transformational. Part of the Vertex global network of venture capital funds, Vertex Growth accesses opportunities emerging from the leading innovation hubs across the world and drive significant value by working closely with the Vertex ecosystem of portfolio companies and partners. For more information about Vertex Growth, please visit: https://vertexgrowth.com

For the latest news on Vertex Ventures SE Asia and India and our portfolio companies, follow us on Linkedin or subscribe to our monthly newsletter.